Verition Fund Management LLC Pds Biotechnology Corp Transaction History

Verition Fund Management LLC

  • $23.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$4.8 - $6.4 $24,604 - $32,806
-5,126 Reduced 16.59%
25,774 $130,000
Q2 2023

Aug 14, 2023
BUY
$5.03 - $9.9 $39,581 - $77,903
7,869 Added 34.17%
30,900 $155,000
Q1 2023

May 15, 2023
BUY
$5.68 - $11.99 $130,816 - $276,141
23,031 New
23,031 $141,000

Others Institutions Holding PDSB

# of Institutions
59
Shares Held
4.22M
Call Options Held
170K
Put Options Held
6.7K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $38.1M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email